Prognostic analysis of patients who underwent gross total resection of newly diagnosed glioblastoma

被引:12
|
作者
Matsuda, Masahide [1 ]
Kohzuki, Hidehiro [1 ]
Ishikawa, Eiichi [1 ]
Yamamoto, Tetsuya [1 ]
Akutsu, Hiroyoshi [1 ]
Takano, Shingo [1 ]
Mizumoto, Masashi [2 ]
Tsuboi, Koji [2 ]
Matsumura, Akira [1 ]
机构
[1] Univ Tsukuba, Dept Neurosurg, Fac Med, Tsukuba, Ibaraki 3058575, Japan
[2] Univ Tsukuba, Dept Radiat Oncol, Proton Med Res Ctr, Tsukuba, Ibaraki, Japan
关键词
Glioblastoma; Gross total resection; Subventricular zone; Proton beam therapy; SUBVENTRICULAR ZONE; RADIATION-THERAPY; MULTIVARIATE-ANALYSIS; MULTIFORME; SURVIVAL; IRRADIATION; CONCOMITANT; RECURRENCE; EXTENT;
D O I
10.1016/j.jocn.2018.01.009
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Despite cumulative evidence supporting the idea that gross total resection (GTR) contributes to prolonged survival of patients with glioblastoma (GBM), the survival outcome of such patients remains unsatisfactory. To develop more effective postoperative therapeutic strategies for patients who underwent GTR, identification of prognostic factors influencing survival is urgently needed. Here we retrospectively analyzed prognostic factors for patients who underwent GTR of newly diagnosed GBM, with a particular focus on the influence of the subventricular zone (SVZ) as the tumor location. Forty-eight consecutive patients with newly diagnosed GBM who underwent GTR during the initial operation were investigated. Tumor involvement of the SVZ was significantly associated with overall survival (OS). The SVZ-positive group had a significantly shorter median OS of 12.2 months, compared to 34.9 months for the SVZ-negative group. The occurrence of leptomeningeal dissemination was significantly influenced by tumor involvement of the SVZ, but was not significantly influenced by ventricular opening during surgery. We observed a statistically significant difference in OS according to radiation modality. The median OS was 36.9 months for patients treated with high-dose proton beam therapy, compared with 26.2 months for patients treated with conventional radiotherapy. We demonstrated that tumor involvement of the SVZ was associated with poor survival of patients who underwent GTR of newly diagnosed GBM, suggesting the potential need for therapeutic strategies that specifically target tumors in the SVZ. Further prospective studies to evaluate whether radiotherapy targeting the SVZ improves survival of patients with tumor involvement of the SVZ who had undergone GTR are warranted. (C) 2018 Elsevier Ltd. All rights reserved.
引用
收藏
页码:172 / 176
页数:5
相关论文
共 50 条
  • [41] Preradiation Chemotherapy with ACNU-CDDP in Patients with Newly Diagnosed Glioblastoma: A Retrospective Analysis
    Han, Jung Ho
    Park, Chul-Kee
    Lee, Se-Hoon
    Kim, Chae-Yong
    Kim, Dong-Wan
    Paek, Sun Ha
    Kim, Dong Gyu
    Heo, Dae Seog
    Kim, Il Han
    Jung, Hee-Won
    CHEMOTHERAPY, 2009, 55 (03) : 145 - 154
  • [42] The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
    Li, Yan Michael
    Suki, Dima
    Hess, Kenneth
    Sawaya, Raymond
    JOURNAL OF NEUROSURGERY, 2016, 124 (04) : 977 - 988
  • [43] Pre-Radiotherapy Progression after Surgery of Newly Diagnosed Glioblastoma: Corroboration of New Prognostic Variable
    Lakomy, Radek
    Kazda, Tomas
    Selingerova, Iveta
    Poprach, Alexandr
    Pospisil, Petr
    Belanova, Renata
    Fadrus, Pave
    Smrcka, Martin
    Vybihal, Vaclav
    Jancalek, Radim
    Kiss, Igor
    Muckova, Katarina
    Hendrych, Michal
    Knight, Andrea
    Sana, Jiri
    Slampa, Pavel
    Slaby, Ondrej
    DIAGNOSTICS, 2020, 10 (09)
  • [44] Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients
    Tanaka, Shota
    Meyer, Fredric B.
    Buckner, Jan C.
    Uhm, Joon H.
    Yan, Elizabeth S.
    Parney, Ian F.
    JOURNAL OF NEUROSURGERY, 2013, 118 (04) : 786 - 798
  • [45] Temozolomide with or without Radiotherapy in Patients with Newly Diagnosed Glioblastoma Multiforme: A Meta-Analysis
    Feng, Enshan
    Sui, Changbai
    Wang, Tongxin
    Sun, Gaoling
    EUROPEAN NEUROLOGY, 2017, 77 (3-4) : 201 - 210
  • [46] Use of metformin and outcome of patients with newly diagnosed glioblastoma: Pooled analysis
    Seliger, Corinna
    Genbrugge, Els
    Gorlia, Thierry
    Chinot, Olivier
    Stupp, Roger
    Nabors, Burt
    Weller, Michael
    Hau, Peter
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (03) : 803 - 809
  • [47] Preoperative Naples prognostic score is a reliable prognostic indicator for newly diagnosed glioblastoma patients
    Li, Junhong
    Yang, Wanchun
    Yuan, Yunbo
    Zuo, Mingrong
    Li, Tengfei
    Wang, Zhihao
    Liu, Yanhui
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [48] Elderly patients with newly diagnosed glioblastoma: can preoperative imaging descriptors improve the predictive power of a survival model?
    Park, Mina
    Lee, Seung-Koo
    Chang, Jong Hee
    Kang, Seok-Gu
    Kim, Eui Hyun
    Kim, Se Hoon
    Song, Mi Kyung
    Ma, Bo Gyoung
    Ahn, Sung Soo
    JOURNAL OF NEURO-ONCOLOGY, 2017, 134 (02) : 423 - 431
  • [49] Retrospective comparison of standard and escalated doses of radiotherapy in newly diagnosed glioblastoma patients treated with concurrent and adjuvant temozolomide
    Guler, Ozan Cem
    Yildirim, Berna Akkus
    Onal, Cem
    Topkan, Erkan
    INDIAN JOURNAL OF CANCER, 2019, 56 (01) : 59 - 64
  • [50] Advantages of gross total resection in patients with astrocytoma: A population-based study
    Mao, Hua
    Li, Xianguo
    Mao, Weipu
    ONCOLOGY LETTERS, 2020, 19 (06) : 3761 - 3774